| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |